Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination

Lancet Rheumatol. 2022 Feb;4(2):e85-e87. doi: 10.1016/S2665-9913(21)00372-6. Epub 2021 Dec 8.

Authors

Medha Barbhaiya^{1

2

3}, Jonah M Levine¹, Vivian P Bykerk^{1

2}, Lisa A Mandl^{1

2

3}

Affiliations

¹ Division of Rheumatology, Hospital for Special Surgery, New York, NY 10021, USA.
² Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
³ Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.

No abstract available

Grants and funding

UL1 TR002384/TR/NCATS NIH HHS/United States